Biomaterial promotes bone growth

GEORGETOWN, TX – DiFusion Technologies has announced the completion of clinical tests which substantiate their claim that their CleanFUZE biomaterial resists surgical infection and promotes bone growth.

"Our clinical tests have shown repeatedly that we have a new biomaterial which eradicates MRSA bacterium 99.998%," said Joseph Crudden, PhD, vice president of Research at DiFusion. The new load-bearing polymer can be used to engineer orthopedic or dental implants.

According to Professor Hans Jorg Meisel, M.D., PhD, the director for the Center of Neurosciences and the Chair of the Department of Neurosurgery at BG-Clinic Bergmannstrost, Halle, Germany, "An orthobiologic material that resists infection and osteointegrates with bone would be the holy-grail of orthopedics. What more could we ask of an implant or material?"

CleanFUZE is the first material-based solution that can actively kill MRSA while preventing biofilm adhesion.  It will first be introduced in the European Union via CE Mark in 2013 with subsequent FDA clearance in 2014.